Steven Perrin

Steven Perrin

Vermogen: 3 810 $ op 31-05-2026

61 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Steven N.
Perrin
is the founder of Anelixis Therapeutics, Inc., founded in 2013, where the titles held included President, CEO, Treasurer & Director.
Current jobs include Executive Chairman at ALS Therapy Development Foundation, Inc. since 2018 (job started in 2007) and President, Chief Scientific Officer & Director at Eledon Pharmaceuticals, Inc. since 2020.
Former jobs include Associate Director-Molecular Profiling at Biogen, Inc. from 2001 to 2006, Scientist at Biogen MA, Inc., ARIAD Pharmaceuticals, Inc., and Aventis Pharmaceuticals, Inc., Assistant Professor at Boston University, Principal at Hoechst Ariad Genomics Center Llc, and Associate Professor at Boston University School of Medicine.
Education includes an undergraduate degree from Boston College in 1987 and a doctorate from Boston University School of Medicine in 1994.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-03-2026 1.000 ( 0% ) 3 810 $ 31-05-2026

Actieve functies van Steven Perrin

BedrijvenFunctieBegin
ELEDON PHARMACEUTICALS, INC. President 14-09-2020
Voorzitter 01-06-2010

Eerdere bekende functies van Steven Perrin

BedrijvenFunctieEinde
BIOGEN INC. Corporate Officer/Principal 01-12-2006
Corporate Officer/Principal -
Oprichter -
Corporate Officer/Principal -
Corporate Officer/Principal -
Ervaring van Steven Perrin in detail bekijken

Opleiding van Steven Perrin

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

85

Eerstegraads connecties

11

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Commercial Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Steven Perrin
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU